HBW
NUTX

Hazlett, Burt & Watson’s Nutex Health NUTX Stock Holding History

Hazlett, Burt & Watson’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64
Closed -$8K – 911
2025
Q2 		$8K Buy
+64
New +$8.27K ﹤0.01% 620

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hazlett, Burt & Watson's NUTX Position: Q3 2025 in Review

Hazlett, Burt & Watson sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 64 shares — an estimated $8K sold.

Hazlett, Burt & Watson first reported a position in NUTX in Q2 2025 and held it in 1 quarter. The position peaked at $8K in Q2 2025. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

  • Hazlett, Burt & Watson reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 64 Nutex Health shares in Q3 2025, an estimated $8K.
  • Hazlett, Burt & Watson first reported a position in Nutex Health in Q2 2025 and held it in 1 quarter.
  • Hazlett, Burt & Watson's Nutex Health position peaked at $8K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2025, filed 4 Nov 2025.